Gyre Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 29, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	653	1,038	1,967	-
Market Cap Growth	-30.81%	-47.22%	-	-
Enterprise Value	596	1,050	1,946	-
Last Close Price	7.26	12.10	25.69	-
PE Ratio	183.08	85.93	-	-
PS Ratio	5.92	9.82	17.34	-
PB Ratio	6.47	10.55	25.07	-
P/TBV Ratio	6.74	16.85	-	-
P/FCF Ratio	225.97	-	113.23	-
P/OCF Ratio	168.79	-	75.99	-
EV/Sales Ratio	5.55	9.93	17.15	-
EV/EBITDA Ratio	41.47	58.96	95.72	-
EV/EBIT Ratio	49.49	64.73	101.27	-
EV/FCF Ratio	205.64	-	111.99	-
Debt / Equity Ratio	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.08	0.09	0.02	0.06
Debt / FCF Ratio	0.40	-	0.02	0.11
Asset Turnover	0.75	0.87	1.13	-
Inventory Turnover	0.64	0.73	0.89	-
Quick Ratio	5.41	2.64	2.49	3.33
Current Ratio	6.20	3.32	2.85	4.06
Return on Equity (ROE)	10.02%	20.24%	-113.45%	-
Return on Assets (ROA)	5.29%	8.38%	11.93%	-
Return on Capital (ROIC)	6.30%	11.34%	15.83%	-
Return on Capital Employed (ROCE)	8.40%	15.30%	19.90%	12.70%
Earnings Yield	1.02%	1.16%	-4.72%	-
FCF Yield	0.44%	-0.57%	0.88%	-
Buyback Yield / Dilution	-24.46%	-55.39%	13.02%	-

Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q